ABOzymes Biomedical is an early-stage, Vancouver-based enterprise with an innovative, unique, and proprietary platform which will realize a world where blood type is no longer a constraint for those receiving a life-saving transfusion or organ transplant.

Their technology makes all blood O-type (universal donor blood), so any blood can be used for any patient.

Listen to ABOzymes’ interview with The BC Startup Show